Cargando…

Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences

OBJECTIVE: The goal of this study is to investigate obesity and its concomitant effects including the prevalence of comorbidities, its association with patient-reported outcomes and costs, and weight loss strategies in a sample of Mexican adults. METHODS: Mexican adults (N=2,511) were recruited from...

Descripción completa

Detalles Bibliográficos
Autores principales: DiBonaventura, Marco D, Meincke, Henrik, Le Lay, Agathe, Fournier, Janine, Bakker, Erik, Ehrenreich, Allison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743111/
https://www.ncbi.nlm.nih.gov/pubmed/29317841
http://dx.doi.org/10.2147/DMSO.S129247
_version_ 1783288509876928512
author DiBonaventura, Marco D
Meincke, Henrik
Le Lay, Agathe
Fournier, Janine
Bakker, Erik
Ehrenreich, Allison
author_facet DiBonaventura, Marco D
Meincke, Henrik
Le Lay, Agathe
Fournier, Janine
Bakker, Erik
Ehrenreich, Allison
author_sort DiBonaventura, Marco D
collection PubMed
description OBJECTIVE: The goal of this study is to investigate obesity and its concomitant effects including the prevalence of comorbidities, its association with patient-reported outcomes and costs, and weight loss strategies in a sample of Mexican adults. METHODS: Mexican adults (N=2,511) were recruited from a combination of Internet panels and street intercepts using a random-stratified sampling framework, with strata defined by age and sex, so that they represent the population. Participants responded to a survey consisting of a range of topics including sociodemographics, health history, health-related quality of life (HRQoL), work productivity, health care resource use, and weight loss. RESULTS: The sample consisted of 50.6% male with a mean age of 40.7 years (SD=14.5); 38.3% were overweight, and 24.4% were obese. Increasing body mass index (BMI) was associated with increased rates of type 2 diabetes, prediabetes, and hypertension, poorer HRQoL, and decreased work productivity. Of the total number of respondents, 62.2% reported taking steps to lose weight with 27.6% and 17.1% having used an over-the-counter/herbal product and a prescription medication, respectively. Treatment discontinuation rates were high. CONCLUSION: Findings indicated that 62% of participants reported, at least, being overweight and that they were experiencing the deleterious effects associated with higher BMI despite the desire to lose weight. Given the rates of obesity, and its impact on humanistic and societal outcomes, improved education, prevention, and management could provide significant benefits.
format Online
Article
Text
id pubmed-5743111
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-57431112018-01-09 Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences DiBonaventura, Marco D Meincke, Henrik Le Lay, Agathe Fournier, Janine Bakker, Erik Ehrenreich, Allison Diabetes Metab Syndr Obes Original Research OBJECTIVE: The goal of this study is to investigate obesity and its concomitant effects including the prevalence of comorbidities, its association with patient-reported outcomes and costs, and weight loss strategies in a sample of Mexican adults. METHODS: Mexican adults (N=2,511) were recruited from a combination of Internet panels and street intercepts using a random-stratified sampling framework, with strata defined by age and sex, so that they represent the population. Participants responded to a survey consisting of a range of topics including sociodemographics, health history, health-related quality of life (HRQoL), work productivity, health care resource use, and weight loss. RESULTS: The sample consisted of 50.6% male with a mean age of 40.7 years (SD=14.5); 38.3% were overweight, and 24.4% were obese. Increasing body mass index (BMI) was associated with increased rates of type 2 diabetes, prediabetes, and hypertension, poorer HRQoL, and decreased work productivity. Of the total number of respondents, 62.2% reported taking steps to lose weight with 27.6% and 17.1% having used an over-the-counter/herbal product and a prescription medication, respectively. Treatment discontinuation rates were high. CONCLUSION: Findings indicated that 62% of participants reported, at least, being overweight and that they were experiencing the deleterious effects associated with higher BMI despite the desire to lose weight. Given the rates of obesity, and its impact on humanistic and societal outcomes, improved education, prevention, and management could provide significant benefits. Dove Medical Press 2017-12-22 /pmc/articles/PMC5743111/ /pubmed/29317841 http://dx.doi.org/10.2147/DMSO.S129247 Text en © 2018 DiBonaventura et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
DiBonaventura, Marco D
Meincke, Henrik
Le Lay, Agathe
Fournier, Janine
Bakker, Erik
Ehrenreich, Allison
Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
title Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
title_full Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
title_fullStr Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
title_full_unstemmed Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
title_short Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
title_sort obesity in mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743111/
https://www.ncbi.nlm.nih.gov/pubmed/29317841
http://dx.doi.org/10.2147/DMSO.S129247
work_keys_str_mv AT dibonaventuramarcod obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences
AT meinckehenrik obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences
AT lelayagathe obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences
AT fournierjanine obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences
AT bakkererik obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences
AT ehrenreichallison obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences